colonic neoplasm: A benign or malignant neoplasm that affects the colon. Representative examples of benign neoplasms include lipoma and leiomyoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma. Colonic adenomas always exhibit epithelial dysplasia and are considered premalignant neoplasms.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
3783 |
4. Check minimum number of eventsNone |
3783 |
5. Include endpointsNone |
3783 |
6. Filter based on genotype QC (FinnGen only) |
3676 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D32
- Name in latin
- Neoplasma benignum meningum cranialium
Benign neoplasm: Cerebral meninges
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 21809 | 16225 | 5444 |
| Only index persons | 18958 | 14404 | 4554 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.38 | 0.46 | 0.15 |
| Only index persons | 0.44 | 0.53 | 0.17 |
| Median age at first event (years) | |||
| Whole population | 64.57 | 64.55 | 64.62 |
| Only index persons | 64.01 | 63.93 | 64.27 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3676 | 2784 | 892 |
| Unadjusted period prevalence (%) | 0.85 | 0.99 | 0.41 |
| Median age at first event (years) | 63.55 | 62.45 | 66.97 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3783
- Matched controls
- 37830
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
12.2
307.7
490
455
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
241.9
307.7
448
21
N03AX14
ATC
levetiracetam; systemic
11.8
307.7
440
416
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
16384.0
307.7
2265
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
7.4
307.7
546
838
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
3043.2
307.7
973
*
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
7843.2
307.7
662
*
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
+∞
307.7
1299
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
37.4
307.7
335
98
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
345.1
307.7
1450
68
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
1304.0
307.7
459
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
19.0
307.7
1713
1577
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
6.2
307.7
882
1760
ZXC95
NOMESCO Finland
Use of surgical navigator
16.2
285.9
247
162
AA1AD
NOMESCO Finland
CT of head and brain
3.3
275.0
1731
7716
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
470.0
267.2
264
6
D32.06
ICD-10 Finland
Benign tumor of the meninges os petrosum or clivus area
+∞
261.5
248
*
D32.05
ICD-10 Finland
Cerebral meninges
+∞
253.0
240
*
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
29.5
246.0
164
58
N03AF02
ATC
oxcarbazepine; oral
7.4
225.2
342
500
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
9.7
222.7
267
293
D32.03
ICD-10 Finland
Benign meningioma in ventricles
2132.6
220.9
212
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
9.5
216.2
263
294
H02AB02
ATC
dexamethasone; systemic
3.5
205.5
862
2927
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
9.2
190.5
238
275
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
42.3
184.9
111
27
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
9.2
179.6
224
258
2152
FHL
Extraction, big brain
93.2
174.0
91
10
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
+∞
165.9
158
*
D32.07
ICD-10 Finland
Secondary or multiple benign tumor of the meninges below the exam
+∞
159.5
152
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.9
158.5
942
3869
H53.4
ICD-10 Finland
Visual field defects
7.7
151.5
219
301
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
21.0
145.4
110
54
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
31.0
129.9
85
28
2252A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
+∞
128.9
123
*
WX882
NOMESCO Finland
High dependency care
6.0
128.2
233
407
XCK00
NOMESCO Finland
Perimetry
3.6
124.2
456
1394
9531/0-C70.0
ICD-O-3
Meningothelial meningioma of cerebral meninges
+∞
121.5
116
*
N03AB02
ATC
phenytoin; systemic
9.6
116.8
139
150
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.0
111.0
249
526
H47.2
ICD-10 Finland
Optic atrophy
20.2
110.8
85
43
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.3
108.9
225
442
ZXC40
NOMESCO Finland
Use of ultrasound
12.2
98.8
99
83
N76
ICPC
Neoplasm nervous system unspecified
47.4
95.6
56
12
D33.30
ICD-10 Finland
Acoustic neuroma
12.0
94.7
96
82
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
9.9
92.4
107
111
9539/1-C70.0
ICD-O-3
Atypical meningioma of cerebral meninges
+∞
91.0
87
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
90.0
1189
6762
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
6.0
89.5
162
281
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
6.8
88.8
141
214
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
20.7
88.2
67
33
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
25.8
87.7
61
24
9537/0-C70.0
ICD-O-3
Transitional meningioma of cerebral meninges
868.0
87.0
85
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
84.2
679
3146
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
14.0
83.6
77
56
R51.80
ICD-10 Finland
Headache
2.3
83.3
749
3637
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
9.3
80.9
98
108
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
11.8
78.4
80
69
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
8.5
76.7
100
121
G40.10
ICD-10 Finland
Simple partial seizures
11.0
76.6
82
76
XA800
NOMESCO Finland
Neuropsychological investigation
3.9
75.4
235
638
N03AX18
ATC
lacosamide; systemic
11.7
75.0
77
67
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.6
73.2
250
722
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
19.3
72.8
57
30
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
10.0
72.3
83
85
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
3.7
72.3
236
661
8000/0-C70.0
ICD-O-3
Neoplasm, benign of cerebral meninges
711.5
71.3
70
*
WF099
NOMESCO Finland
Other radiotherapy
10.0
70.5
81
83
N03AF01
ATC
carbamazepine; oral, rectal
3.2
70.1
299
993
D32
ICD-10 Finland
Benign neoplasm of meninges
338.0
66.7
67
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
66.2
820
4478
9532/0-C70.0
ICD-O-3
Fibrous meningioma of cerebral meninges
+∞
64.8
62
*
22520
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
+∞
63.7
61
*
WF002
NOMESCO Finland
Radical radiotherapy
3.2
63.4
267
879
ZX050
NOMESCO Finland
Stereotactic radiotherapy
8.3
62.0
82
101
CS494
NOMESCO Finland
Other visual field testing
3.9
59.6
178
468
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
9.2
57.8
70
77
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
10.7
57.7
63
60
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
55.0
898
5350
N75
ICPC
Benign neoplasm nervous system
101.6
55.0
60
6
D42.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Cerebral meninges
87.2
54.0
60
7
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
14.3
52.8
48
34
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
10.7
50.6
55
52
183
Kela drug reimbursment
Lamotrigin and topiramate
7.9
50.2
69
89
AAK00
NOMESCO Finland
Cranioplasty
72.2
50.1
57
8
WX402
NOMESCO Finland
General anaesthesia
1.8
49.5
853
5148
N03AG01
ATC
valproic acid; systemic, rectal
2.7
49.3
275
1056
H02AB09
ATC
hydrocortisone; systemic
4.0
48.5
140
359
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.9
48.1
235
841
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
6.6
48.0
77
118
E23.00
ICD-10 Finland
Panhypopituitarism
11.8
47.2
48
41
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.1
46.5
516
2676
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
6.0
46.0
82
140
A02BC02
ATC
pantoprazole; systemic
1.7
45.2
2712
22637
R42
ICD-10 Finland
Dizziness and giddiness
1.7
45.1
1018
6625
C70.0
ICD-10 Finland
Malignant neoplasm: Cerebral meninges
155.2
43.9
46
*
H53.2
ICD-10 Finland
Diplopia
3.2
43.4
181
591
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
7.0
42.8
65
94
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
56.3
42.5
50
9
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.2
42.2
387
1861
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
41.1
2597
21656
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
8.1
40.9
55
69
H47.1
ICD-10 Finland
Papilloedema, unspecified
8.9
40.2
50
57
N02BE01
ATC
paracetamol; systemic, rectal
2.1
39.9
3432
31075
TAB00
NOMESCO Finland
Lumbar puncture
2.8
39.3
205
759
WX872
NOMESCO Finland
Intensive care
2.7
39.1
227
888
101
Kela drug reimbursment
Anterior pituitary hypofunction
9.0
39.0
48
54
R4110
NOMESCO Finland
Physiotherapy
1.6
39.0
1117
7691
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.0
36.1
439
2342
D33.02
ICD-10 Finland
Another benign medial tumor of the cerebrum
68.9
36.0
41
6
Z3231
NOMESCO Finland
Registered nurse
1.6
35.8
1049
7235
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
34.1
629
3829
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
33.5
1488
11249
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
5.1
33.4
70
139
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
38.6
33.4
42
11
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
49.2
32.5
39
8
S18
ICPC
Laceration/cut
1.5
32.5
1747
13721
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
12.4
32.4
32
26
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.9
32.0
427
2347
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
30.6
1387
10476
XX3DW
NOMESCO Finland
Time consuming IT work
1.8
28.8
455
2637
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
10.8
28.7
31
29
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.0
27.7
125
428
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.1
27.5
284
1424
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
5.7
27.4
51
91
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.7
27.2
572
3593
G91.1
ICD-10 Finland
Obstructive hydrocephalus
7.6
26.3
37
49
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
26.3
1737
13996
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
25.9
26.1
36
14
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
37.0
26.1
33
9
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
6.2
25.3
43
70
R4150
NOMESCO Finland
Neuropsychological rehabilitation
6.0
25.1
44
74
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
2.9
25.1
119
419
ZXC86
NOMESCO Finland
Use of endoscopic device
7.0
24.6
37
53
SPAT1153
SPAT
Removal of sutures
1.5
24.1
1208
9201
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
2.4
24.0
172
743
DFF00
NOMESCO Finland
Pure tone audiometry
1.8
23.7
408
2418
9530/0-C70.1
ICD-O-3
Meningioma, NOS, of spinal meninges
54.4
23.0
27
5
AWC00
NOMESCO Finland
Reoperation of nervous system because of deep wound infection in the nervous system
54.4
23.0
27
5
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
8.0
23.0
31
39
Z3229
NOMESCO Finland
Other healthcare associate professional
1.9
22.7
324
1814
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
2.7
21.9
120
456
N88
ICPC
Epilepsy
6.4
21.8
36
57
PA2AD
NOMESCO Finland
CT angiography of brain
4.8
21.7
49
104
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
2.7
21.7
120
459
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
21.5
829
5973
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
21.5
670
4614
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
3.6
21.4
69
192
N05CF01
ATC
zopiclone; oral
1.4
21.4
1237
9626
L28
ICPC
Limited function/disability (L)
1.5
21.3
724
5079
R90.0
ICD-10 Finland
Intracranial space-occupying lesion
23.2
21.2
30
13
R51
ICD-10 Finland
Headache
2.1
20.9
199
967
R53
ICD-10 Finland
Malaise and fatigue
1.5
20.8
867
6336
9537/0-C70.9
ICD-O-3
Transitional meningioma of meninges, NOS
+∞
20.8
20
*
D33.0
ICD-10 Finland
Benign neoplasm: Brain, supratentorial
+∞
20.8
20
*
G44.2
ICD-10 Finland
Tension-type headache
1.6
20.8
512
3333
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
4.0
20.6
59
151
9539/1-C70.9
ICD-O-3
Atypical meningioma of meninges, NOS
211.1
20.6
21
*
H49.1
ICD-10 Finland
Fourth [trochlear] nerve palsy
5.3
20.6
41
78
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.0
20.5
244
1286
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
8.2
20.5
27
33
R4120
NOMESCO Finland
Occupational therapy
1.9
20.0
249
1332
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
7.0
19.9
30
43
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
3.2
19.8
80
257
9531/0-C70.9
ICD-O-3
Meningothelial meningioma of meninges, NOS
+∞
19.8
19
*
Z3226
NOMESCO Finland
Physiotherapist
1.5
19.5
674
4737
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
8.4
19.3
25
30
S06.0
ICD-10 Finland
Concussion
1.7
19.2
373
2283
Z2445
NOMESCO Finland
Psychologist
2.5
18.6
119
489
N06AX11
ATC
mirtazapine; oral
1.4
18.5
1222
9674
G40.89
ICD-10 Finland
Other epilepsy
6.4
18.4
30
47
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
5.7
18.0
33
58
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.8
18.0
267
1511
G40
ICD-10 Finland
Epilepsy
4.4
17.8
44
101
N05BA09
ATC
clobazam; oral
5.9
17.4
31
53
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
5.5
17.4
33
60
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
17.4
981
7544
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.3
16.8
129
576
N01
ICPC
Headache
1.7
16.7
328
2011
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
16.7
1235
9915
2151
FHL
Resection, big brain
63.6
16.7
19
*
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.5
16.6
652
4686
D33.08
ICD-10 Finland
Another benign tumor of the cerebral ventricle
90.5
16.6
18
*
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.3
16.5
131
593
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
3.4
16.3
59
178
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
2.1
16.1
147
703
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
2.6
15.9
89
343
TPH07
NOMESCO Finland
Cathetrisation of artery
1.6
15.8
392
2552
H93.1
ICD-10 Finland
Tinnitus
1.8
15.7
255
1482
ZXA10
NOMESCO Finland
Bilateral
1.4
15.7
691
5070
G47.3
ICD-10 Finland
Sleep apnoea
1.4
15.7
689
5055
N03AX09
ATC
lamotrigine; oral
2.1
15.1
142
688
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
45.2
15.1
18
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
15.0
1705
14515
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
14.9
252
1484
ZXA00
NOMESCO Finland
Right side
1.4
14.8
983
7731
ZXA05
NOMESCO Finland
Left side
1.4
14.7
912
7098
G50.0
ICD-10 Finland
Trigeminal neuralgia
2.6
14.6
83
323
J01DB01
ATC
cefalexin; oral
1.4
14.6
2936
27067
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.4
14.5
100
426
G91.0
ICD-10 Finland
Communicating hydrocephalus
4.8
14.5
32
67
22500
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
150.6
14.5
15
*
H02AB06
ATC
prednisolone; systemic
1.3
14.5
1690
14421
2250A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
36.2
14.4
18
5
R4130
NOMESCO Finland
Speech therapy
2.4
14.4
98
415
AAK10
NOMESCO Finland
Repair of dura
17.0
14.3
22
13
N03AX16
ATC
[U] pregabalin
1.4
14.2
850
6566
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
14.2
1376
11430
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.9
14.2
41
106
UKC02
NOMESCO Finland
Cystoscopy
1.5
14.2
504
3545
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
14.1
745
5636
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.6
14.1
357
2331
WX704
NOMESCO Finland
Intubation
1.7
14.1
276
1692
ZXD05
NOMESCO Finland
Urgent procedure
1.4
13.9
980
7769
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.6
13.8
291
1819
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
13.6
13.7
23
17
N03AX23
ATC
brivaracetam; systemic
13.6
13.7
23
17
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
13.7
1115
9028
N03AX11
ATC
topiramate; oral
2.5
13.6
86
352
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
4.0
13.6
38
96
2396A
ICD-9 Finland
Neoplasm of unspecified nature, Brain
75.4
13.6
15
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.7
13.5
256
1554
R20.2
ICD-10 Finland
Paraesthesia of skin
1.7
13.5
232
1373
H05.2
ICD-10 Finland
Exophthalmic conditions
10.1
13.4
26
26
D44.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pituitary gland
10.1
13.4
26
26
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.8
13.4
185
1024
N03AX12
ATC
[U] gabapentin; oral
1.4
13.4
596
4374
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.2
13.4
112
519
PA6AD
NOMESCO Finland
CT of neck arteries
2.2
13.3
109
501
H54.4
ICD-10 Finland
Blindness, monocular
5.7
13.2
24
42
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
40.2
13.1
16
*
A28
ICPC
Limited function/disability NOS
1.4
13.1
647
4837
N99
ICPC
Neurological disease other
3.0
13.0
56
188
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.0
13.0
145
749
G96.0
ICD-10 Finland
Cerebrospinal fluid leak
19.1
12.9
19
10
P20
ICPC
Memory disturbance
1.4
12.9
525
3788
N29
ICPC
Neurological sympt/complt other
2.5
12.8
80
326
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.5
12.7
386
2627
N74
ICPC
Malignant neoplasm nervous system
15.5
12.6
20
13
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.5
12.6
78
317
D42.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Meninges, unspecified
70.1
12.6
14
*
9533/0-C70.0
ICD-O-3
Psammomatous meningioma of cerebral meninges
+∞
12.5
12
*
8000/0-C70.9
ICD-O-3
Neoplasm, benign of meninges, NOS
+∞
12.5
12
*
R13
ICD-10 Finland
Dysphagia
1.7
12.5
251
1549
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
9.3
12.5
25
27
2040A
ICD-9 Finland
Lymphoid leukaemia, Acute
130.4
12.4
13
*
N18
ICPC
Paralysis/weakness
2.5
12.4
77
313
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.0
12.4
137
705
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
3.1
12.3
49
157
D33.37
ICD-10 Finland
Another benign tumor of the cranial nerves
37.7
12.2
15
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.7
12.1
211
1252
SPAT1053
SPAT
Memory test
1.4
12.1
544
3996
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.7
12.1
227
1377
A02BC05
ATC
esomeprazole; systemic
1.3
11.9
1450
12343
WX892
NOMESCO Finland
Monitored bed care
1.6
11.7
245
1529
AWW99
NOMESCO Finland
Other reoperation in surgery of the nervous system
30.1
11.6
15
5
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
11.6
364
2491
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.5
11.6
339
2286
H53.1
ICD-10 Finland
Subjective visual disturbances
1.6
11.5
241
1502
H03AA01
ATC
levothyroxine sodium; systemic
1.3
11.5
910
7305
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
2.5
11.5
68
271
9532/0-C70.9
ICD-O-3
Fibrous meningioma of meninges, NOS
+∞
11.5
11
*
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
11.4
2248
20243
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
3.2
11.4
45
144
XKD00
NOMESCO Finland
Uroflowmetry
1.5
11.3
387
2697
R55
ICD-10 Finland
Syncope and collapse
1.5
11.3
374
2589
AA1AA
NOMESCO Finland
Head X-ray examination
3.4
11.2
40
120
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
3.0
11.2
48
161
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
5.0
11.0
23
46
E21.0
ICD-10 Finland
Primary hyperparathyroidism
2.3
10.9
77
333
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
10.9
339
2318
H46
ICD-10 Finland
Optic neuritis
3.4
10.8
38
113
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
10.6
10.8
20
19
D33.3
ICD-10 Finland
Benign neoplasm: Cranial nerves
21.5
10.7
15
7
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.5
10.7
401
2846
AAF00
NOMESCO Finland
Ventriculostomy
3.9
10.6
31
81
C08CA01
ATC
amlodipine; oral
1.3
10.6
1377
11764
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
2.6
10.5
58
223
G51.0
ICD-10 Finland
Bell palsy
2.1
10.5
91
429
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.5
10.5
385
2720
R25.1
ICD-10 Finland
Tremor, unspecified
2.0
10.5
112
571
N17
ICPC
Vertigo/dizziness
1.4
10.5
450
3274
Q85.1
ICD-10 Finland
Tuberous sclerosis
110.3
10.4
11
*
20400
ICD-8 Finland
Lymphatic leukaemia, Acute
+∞
10.4
10
*
H01AC01
ATC
somatropin; parenteral
32.6
10.3
13
*
M54.5
ICD-10 Finland
Low back pain
1.3
10.1
1189
10026
WX002
NOMESCO Finland
Sedation and analgesia
1.3
10.0
684
5361
D33.39
ICD-10 Finland
Benign tumor of the cranial nerves UNS
14.6
10.0
16
11
D33.05
ICD-10 Finland
Other lateral benign tumor in temporal lobe
40.2
10.0
12
*
A02BC03
ATC
lansoprazole; oral
1.3
9.9
1019
8444
Z71.8
ICD-10 Finland
Other specified counselling
1.3
9.9
972
8009
N28
ICPC
Limited function/disability (N)
2.4
9.9
66
279
N06AX16
ATC
venlafaxine; oral
1.4
9.8
441
3232
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
1.8
9.8
149
852
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
3.0
9.8
41
136
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
8.7
9.8
20
23
CE2W4
NOMESCO Finland
Eye movement mapping
9.5
9.7
19
20
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.7
9.7
169
1004
K90
ICPC
Stroke/cerebrovascular accident
2.0
9.7
101
510
T32.0
ICD-10 Finland
Corrosions involving less than 10% of body surface
55.1
9.6
11
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
9.6
1018
8463
SPAT1216
SPAT
Assessment of functional ability
1.4
9.6
562
4304
N06AX26
ATC
vortioxetine; oral
1.6
9.6
194
1201
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
9.5
1351
11621
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
9.5
432
3171
D33.45
ICD-10 Finland
Benign Schwannom in the nerve root of the spinal cord
9.1
9.5
19
21
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
4.0
9.5
26
65
N05BA01
ATC
diazepam; systemic, rectal
1.4
9.4
438
3228
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
9.4
960
7941
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.6
9.4
208
1317
ZXE00
NOMESCO Finland
One hour or less
1.3
9.4
1287
11028
H57.1
ICD-10 Finland
Ocular pain
1.9
9.3
121
659
N80
ICPC
Head injury other
2.3
9.3
69
305
ZXD35
NOMESCO Finland
Usual procedure
1.9
9.3
111
588
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
4.9
9.3
20
41
R5140
NOMESCO Finland
Monitoring the use of the aid
1.5
9.3
324
2266
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
10.7
9.3
17
16
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.3
9.3
672
5310
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
2.8
9.2
45
163
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
7.3
9.2
21
29
N02AX02
ATC
tramadol; systemic, rectal
1.2
9.2
1450
12611
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
2.2
9.1
73
335
9560/0-C72.4
ICD-O-3
Schwannoma, NOS, of acoustic nerve
7.0
9.0
21
30
UJF32
NOMESCO Finland
Coloscopy
1.3
8.9
912
7536
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
18.6
8.9
13
7
E23.2
ICD-10 Finland
Diabetes insipidus
7.4
8.9
20
27
D33.43
ICD-10 Finland
Spinal cord
24.1
8.9
12
5
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
2.2
8.9
72
331
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
1.9
8.8
100
521
N06AB10
ATC
escitalopram; oral
1.3
8.8
587
4577
M03BX01
ATC
baclofen; systemic
2.3
8.8
67
300
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
2.9
8.8
39
134
J01MA02
ATC
ciprofloxacin; systemic
1.2
8.8
1278
11004
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
8.7
583
4551
E22.1
ICD-10 Finland
Hyperprolactinaemia
3.6
8.5
27
75
2159
FHL
Other measure in this category
16.3
8.5
13
8
R41.0
ICD-10 Finland
Disorientation, unspecified
1.9
8.5
102
542
B01AB05
ATC
enoxaparin; parenteral
1.3
8.5
1117
9496
102
Kela drug reimbursment
Diabetes insipidus
6.9
8.5
20
29
N07CA01
ATC
betahistine; oral
1.5
8.5
263
1795
WX725
NOMESCO Finland
Noninvasive ventilation
1.6
8.5
169
1043
SDA03
NOMESCO Finland
Periodontal treatment
1.2
8.5
1235
10623
AA1CF
NOMESCO Finland
Extensive MRI examination of brain with median intensity magnet
20.1
8.5
12
6
N04BC06
ATC
cabergoline; oral
4.2
8.4
22
53
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.3
8.4
1005
8451
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
4.7
8.3
19
41
Z85.6
ICD-10 Finland
Personal history of leukaemia
+∞
8.3
8
*
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.2
8.3
1770
15829
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.3
8.3
531
4116
DFF59
NOMESCO Finland
Other assessment of balance
2.7
8.3
44
167
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
8.2
566
4433
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
7.1
8.2
19
27
2180A
ICD-9 Finland
Uterine leiomyoma, Submucous leiomyoma of uterus
1.5
8.2
234
1571
AA1BG, ,
SPAT
2.3
8.2
57
246
S09.9
ICD-10 Finland
Unspecified injury of head
2.3
8.2
57
246
SPAT1301
SPAT
No procedures
1.2
8.2
1042
8826
G35
ICD-10 Finland
Multiple sclerosis
2.4
8.1
53
222
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.4
8.1
349
2537
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.2
8.1
1181
10145
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.3
8.1
754
6148
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.7
8.1
143
855
AAK99
NOMESCO Finland
Other operation on skull or dura
33.4
8.1
10
*
G93.0
ICD-10 Finland
Cerebral cysts
4.0
8.1
22
55
XCK10
NOMESCO Finland
Photography of fundus of eye
1.4
8.0
311
2221
G04BD12
ATC
mirabegron; oral
1.4
8.0
425
3202
N02AJ06
ATC
codeine and paracetamol; systemic
1.2
8.0
1356
11836
A06AD11
ATC
lactulose; oral
1.3
8.0
495
3819
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.3
8.0
547
4282
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
2.0
8.0
86
442
N19
ICPC
Speech disorder
2.6
7.9
44
171
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
2.3
7.9
59
263
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
7.9
698
5656
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
13.0
7.9
13
10
R52.9
ICD-10 Finland
Pain, unspecified
1.4
7.8
313
2250
D33.15
ICD-10 Finland
Another benign tumor of the cerebellum
45.1
7.7
9
*
K91
ICPC
Cerebrovascular disease
2.3
7.7
53
228
R5110, ,
SPAT
1.5
7.7
234
1593
XF400
NOMESCO Finland
ECG with 12 standard connections
1.3
7.7
496
3848
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
3.9
7.7
22
57
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
2.8
7.7
36
128
AA1AM
NOMESCO Finland
Short MRI examination of brain with 3 Tesla magnet
7.4
7.7
17
23
A01
ICPC
Pain general/multiple sites
1.4
7.6
311
2242
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.3
7.6
620
4969
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
18.4
7.6
11
6
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.3
7.6
481
3722
C09CA01
ATC
losartan; oral
1.3
7.6
891
7466
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
7.6
431
3282
AAE99
NOMESCO Finland
Other operation by cranial base approach
25.0
7.6
10
*
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.4
7.6
325
2363
N06AX21
ATC
duloxetine; oral
1.4
7.5
381
2848
H02.2
ICD-10 Finland
Lagophthalmos
4.2
7.5
19
45
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.5
7.4
204
1359
H47.3
ICD-10 Finland
Other disorders of optic disc
4.4
7.4
18
41
D33.01
ICD-10 Finland
Medial ganglion glioma of the cerebrum
80.3
7.4
8
*
21899
ICD-8 Finland
Uterine fibroma
1.6
7.4
179
1160
N86
ICPC
Multiple sclerosis
3.3
7.4
26
78
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
1.5
7.4
235
1616
WZA90
NOMESCO Finland
Other medical or dental certificate
1.3
7.4
700
5719
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
7.3
1470
13015
N05BA04
ATC
oxazepam; oral
1.2
7.3
870
7297
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
7.3
1181
10236
R93.0
ICD-10 Finland
Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified
6.8
7.3
17
25
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
9.4
7.3
14
15
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.4
7.2
328
2407
G50.1
ICD-10 Finland
Atypical facial pain
2.1
7.2
67
326
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
3.2
7.2
27
84
BBA30
NOMESCO Finland
Excision of lesion of parathyroid gland
2.4
7.2
49
210
H81.3
ICD-10 Finland
Other peripheral vertigo
1.8
7.2
99
552
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
1.9
7.2
87
466
Z2446
NOMESCO Finland
Social worker
1.5
7.2
184
1209
AA6AD
NOMESCO Finland
Cranial bones CT examination
30.1
7.1
9
*
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
3.6
7.1
23
65
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
2.1
7.1
64
308
B01AF02
ATC
apixaban; oral
1.3
7.1
423
3242
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
7.1
400
3042
AA4CM
NOMESCO Finland
Extensive MRI examination of sella turcica with 3 Tesla magnet
12.0
7.1
12
10
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
12.0
7.1
12
10
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.6
7.0
142
881
C10AA05
ATC
atorvastatin; oral
1.2
7.0
1424
12610
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
1.6
7.0
150
946
UDC00
NOMESCO Finland
Ear microscopy
1.5
6.9
226
1562
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.7
6.9
128
777
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
1.6
6.9
172
1123
H54.7
ICD-10 Finland
Unspecified visual loss
3.1
6.9
28
92
J02AC01
ATC
fluconazole; systemic
1.2
6.9
1380
12200
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
6.9
1655
14881
Z01.2
ICD-10 Finland
Dental examination
1.2
6.9
1409
12482
KMAK, ,
NOMESCO Finland
1.2
6.8
1585
14199
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
8.3
6.8
14
17
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
10.9
6.8
12
11
D33.06
ICD-10 Finland
Plexus papilloma of the ventricle of the brain
40.1
6.8
8
*
D33
ICD-10 Finland
Benign neoplasm of brain and other parts of central nervous system
40.1
6.8
8
*
C71.40
ICD-10 Finland
Malignant tumor of the occipital lobe without histology
16.7
6.7
10
6
23810
ICD-8 Finland
Neoplasm of unspecified nature of eye, brain and other parts of nervous system, Brain
16.7
6.7
10
6
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.4
6.7
302
2213
U02
ICPC
Urinary frequency/urgency
1.3
6.7
506
4009
R11
ICD-10 Finland
Nausea and vomiting
1.4
6.7
273
1967
SPAT1229
SPAT
Assessment of need for aid
1.4
6.7
262
1875
D43.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other parts of central nervous system
22.5
6.7
9
*
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.5
6.7
183
1221
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
6.4
6.6
16
25
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.4
6.6
240
1693
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.4
6.6
370
2810
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.7
6.6
110
649
A04
ICPC
Weakness/tiredness general
1.3
6.6
458
3589
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.7
6.6
111
657
K07.60
ICD-10 Finland
Snapping jaw
1.6
6.6
151
967
Z00.0
ICD-10 Finland
General medical examination
1.3
6.6
592
4799
S82
ICPC
Naevus/mole
1.3
6.6
415
3208
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
1.9
6.6
77
408
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.6
6.6
164
1071
R50.9
ICD-10 Finland
Fever, unspecified
1.3
6.6
426
3306
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
3.5
6.6
22
64
ZZF00
NOMESCO Finland
Graft of adipose tissue
2.6
6.5
35
134
M03BX02
ATC
tizanidine; oral
1.2
6.5
2055
18890
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
2.8
6.5
30
106
SPAT1043
SPAT
Audiometry
1.4
6.5
351
2651
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
6.5
93
526
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.3
6.5
362
2750
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
6.4
2099
19343
2192
FHL
Cranioplasty
70.0
6.4
7
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.3
6.4
497
3952
A02BC01
ATC
omeprazole; systemic
1.2
6.4
912
7783
S29
ICPC
Skin symptom/complaint other
1.3
6.4
621
5081
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.4
6.4
239
1697
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
1.5
6.3
167
1105
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.6
6.3
156
1017
H92.0
ICD-10 Finland
Otalgia
1.5
6.3
170
1130
E23.05
ICD-10 Finland
Lack of TSH
5.2
6.3
18
35
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.4
6.3
265
1921
NA2DG
NOMESCO Finland
Thoracal spine very extensive MRI examination with high intensity magnet
5.9
6.3
16
27
J01CA08
ATC
pivmecillinam; oral
1.2
6.3
1577
14194
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
2.4
6.3
39
161
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
18.0
6.3
9
5
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
1.8
6.3
85
473
PA2ET
NOMESCO Finland
Extensive embolisation of a brain tumor
+∞
6.2
6
*
9531/0-C70.1
ICD-O-3
Meningothelial meningioma of spinal meninges
+∞
6.2
6
*
H49.9
ICD-10 Finland
Paralytic strabismus, unspecified
+∞
6.2
6
*
9530/3-C70.0
ICD-O-3
Meningioma, malignant of cerebral meninges
+∞
6.2
6
*
D33.1
ICD-10 Finland
Benign neoplasm: Brain, infratentorial
+∞
6.2
6
*
1921A
ICD-9 Finland
Malignant neoplasm of other and unspecified parts of nervous system, Cerebral meninges
+∞
6.2
6
*
H50.2
ICD-10 Finland
Vertical strabismus
2.8
6.2
29
103
WZC30
NOMESCO Finland
Teaching
1.3
6.2
492
3922
2312
FHL
Extirpation or destruction
26.7
6.2
8
*
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
26.7
6.2
8
*
JN4AD
NOMESCO Finland
Body CT examination
1.4
6.2
308
2296
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
2.1
6.2
56
271
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.2
6.2
764
6422
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.4
6.2
264
1920
C09BA02
ATC
enalapril and diuretics; systemic
1.4
6.2
248
1784
XCH00
NOMESCO Finland
Eye pressure measurement
1.6
6.1
149
968
A98
ICPC
Health maint/preventive medicine
1.4
6.1
3526
34341
G41.0
ICD-10 Finland
Grand mal status epilepticus
7.7
6.1
13
17
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.2
6.1
1447
12948
H90.5
ICD-10 Finland
Sensorineural hearing loss, unspecified
2.3
6.1
43
188
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
1.5
6.1
214
1502
K02.1
ICD-10 Finland
Caries of dentine
1.2
6.1
1775
16171
R35
ICD-10 Finland
Polyuria
1.5
6.0
191
1313
G41.9
ICD-10 Finland
Status epilepticus, unspecified
3.5
6.0
20
58
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
385
175
24.38
307.65
1.6
1.7
—
—
—
0
0
939
3727
3.02
169.31
5.7
7.0
1.00
1.19
mmol/l
0.84
691
2956
568
1662
3.84
167.19
5.2
8.6
24.06
24.43
mmol/l
2.21
560
1610
938
3746
3.00
167.03
5.8
7.0
4.94
5.10
kpa
7.71
904
3561
937
3744
3.00
166.66
5.8
6.9
16.33
12.27
kpa
54.14
903
3557
2466
17293
2.22
114.86
7.5
6.4
1.21
1.22
mmol/l
4.78
2164
14622
2640
19214
2.24
109.34
5.5
4.5
6.63
6.70
mmol/l
1.00
2548
18023
2278
15691
2.14
108.16
6.5
5.7
1.21
1.22
mmol/l
7.23
2107
14187
176
301
6.08
98.72
1.8
1.4
—
—
—
0
0
104
104
10.25
92.25
2.3
2.2
51.35
49.08
umol/l
0.23
87
86
258
658
4.13
90.44
1.5
1.3
68.26
25.11
e6/l
0.94
194
499
258
660
4.12
90.06
1.6
1.4
1475.66
1340.63
e6/l
0.08
199
531
947
4946
2.22
89.05
2.1
2.0
28.87
29.73
s
3.88
913
4791
1604
10288
1.97
85.82
2.3
2.1
164.62
187.89
u/l
0.63
1526
9589
110
147
7.68
77.70
1.9
1.5
—
—
—
0
0
260
749
3.65
76.49
1.3
1.3
697.96
536.68
mg/l
2.72
247
708
240
661
3.81
75.39
1.2
1.2
3.63
3.75
mmol/l
0.97
217
619
1324
8320
1.91
72.14
3.8
3.7
93.92
90.87
%
4.38
1286
8092
2116
15449
1.84
70.99
13.9
15.6
1.22
1.26
inr
1.25
556
4387
607
3011
2.21
62.61
2.7
2.1
372.97
374.20
nmol/l
0.04
563
2738
606
3088
2.15
58.08
7.3
7.7
120.96
119.53
g/l
1.19
594
2993
635
3317
2.10
56.95
7.1
7.4
97.11
95.71
%
9.89
620
3188
2017
15208
1.70
54.14
2.7
2.6
—
—
—
0
0
1218
8024
1.76
53.32
2.3
2.3
—
—
—
0
0
435
2036
2.28
51.07
7.3
8.3
0.72
0.68
%
1.07
435
2023
436
2054
2.27
50.37
7.3
8.3
95.54
93.97
%
11.11
436
2044
197
661
3.09
45.16
2.6
1.6
419.21
309.03
mu/l
2.66
189
600
100
217
4.71
42.97
1.3
1.3
2.47
2.13
mmol/l
0.93
86
203
56
91
6.23
33.03
2.5
1.9
0.74
1.33
ug/l
1.60
56
84
2575
21975
1.54
31.83
5.5
4.9
763.01
2043.58
e6/l
1.42
30
293
2797
24426
1.56
30.05
4.7
4.3
12.83
13.35
mm/h
1.03
2607
22465
383
2076
1.94
29.86
8.8
7.1
24.89
24.67
mmol/l
0.76
371
1962
3447
31800
1.95
29.75
18.7
14.9
20.87
23.39
mg/l
5.57
3005
25296
1962
16000
1.47
28.94
5.9
5.8
0.04
0.04
e9/l
0.01
1697
13712
1957
15964
1.47
28.74
5.9
5.8
0.58
0.58
e9/l
0.07
1691
13682
2892
25539
1.56
28.62
4.9
4.3
14.89
14.91
pmol/l
0.12
2641
23071
2101
17445
1.46
27.69
5.9
6.1
10.41
11.05
umol/l
1.56
1986
16511
3548
33179
2.12
27.68
22.3
17.3
139.66
139.69
mmol/l
0.22
3501
32359
3285
30015
1.72
27.28
5.9
5.2
3.04
2.08
mu/l
0.57
3019
27311
3552
33262
2.11
27.09
22.3
17.4
3.95
3.96
mmol/l
3.51
3501
32393
1988
16378
1.45
27.01
5.9
5.8
1.94
1.91
e9/l
0.20
1752
14373
1607
12721
1.46
26.98
4.1
3.7
35.89
86.43
ng/l
0.80
1172
8969
2886
25593
1.54
26.84
8.1
7.6
77.81
78.96
u/l
0.74
2725
23975
2226
18775
1.45
26.41
9.2
9.1
4.11
4.05
e9/l
0.46
1962
16352
1846
15042
1.44
26.33
6.4
6.3
8.52
8.63
%
0.79
1724
13986
56
113
5.02
26.28
3.1
2.8
29.16
29.11
umol/l
0.01
47
80
2002
16570
1.44
26.19
6.2
5.9
0.18
0.19
e9/l
1.74
1754
14425
1833
14963
1.44
25.62
6.1
6.0
2.72
2.84
%
1.57
1707
13890
1786
14538
1.43
25.20
6.1
6.0
0.67
0.69
%
0.47
1658
13469
1869
15400
1.42
24.30
6.3
6.1
27.74
27.76
%
0.02
1743
14351
212
999
2.19
24.10
5.3
4.1
3.77
3.85
mmol/l
2.17
212
990
1843
15177
1.42
23.88
6.0
5.9
57.64
57.30
%
0.58
1725
14125
115
412
2.85
23.50
3.5
5.2
348.30
363.23
umol/l
0.63
108
357
776
5425
1.54
23.44
2.7
3.1
0.83
0.81
mmol/l
2.53
721
5040
897
6471
1.51
23.37
3.9
3.8
151.56
317.77
ng/l
2.31
687
5165
449
2763
1.71
22.81
6.0
6.8
8.10
9.94
mmol/l
6.48
423
2633
225
1110
2.09
22.73
2.1
2.2
463.76
684.48
ug/l
0.41
207
1038
1735
14263
1.40
22.03
2.1
2.0
98.36
96.47
pmol/l
0.76
851
6962
1781
14760
1.39
21.28
4.7
4.6
35.23
35.27
g/l
0.12
1652
13661
1250
9788
1.41
20.69
3.5
3.2
48.66
72.67
e6/l
1.00
989
7433
758
5438
1.49
19.87
1.8
1.8
—
—
—
0
0
1165
9088
1.41
19.43
3.4
3.1
0.40
0.46
e6/l
0.43
926
6886
302
1744
1.80
19.08
8.2
9.6
—
—
—
0
0
119
483
2.51
19.07
1.6
1.3
12.46
14.65
u/l
0.75
95
383
79
262
3.06
18.59
1.1
1.1
—
—
—
0
0
1419
11510
1.37
18.48
4.1
3.7
69.87
119.14
e6/l
2.93
1053
8052
608
4252
1.51
17.85
5.2
5.2
1.02
1.04
mmol/l
0.94
550
3916
878
6597
1.43
17.84
1.8
1.8
1100.38
1183.48
nmol/l
1.86
644
4935
343
2097
1.70
17.71
3.1
3.2
4.28
4.43
pmol/l
1.76
307
1841
3543
33708
1.81
17.43
21.7
17.6
74.09
75.05
umol/l
1.03
3543
33699
85
306
2.82
17.30
1.0
1.1
—
5.04
—
0
6
63
191
3.34
17.20
1.1
1.1
10.20
13.18
nmol/l
0.11
13
39
2279
20023
1.35
17.04
3.5
3.1
47.55
48.56
u/l
0.23
2111
18387
81
291
2.82
16.56
1.1
1.1
—
85.00
—
0
5
1718
14528
1.33
16.39
2.5
2.3
77.94
79.78
nmol/l
1.93
1508
12886
243
1378
1.82
16.29
5.9
5.5
1.50
1.59
%
1.17
226
1286
55
161
3.45
15.88
1.0
1.1
—
—
—
0
0
51
143
3.60
15.72
1.3
1.3
36.50
66.61
%
—
10
18
211
1167
1.86
15.34
1.5
1.3
32.06
35.20
iu/l
0.68
188
1014
62
204
3.07
14.85
1.2
1.1
55.89
38.18
mg/l
1.06
55
173
348
2244
1.61
14.53
2.3
2.4
16.24
24.45
au/ml
1.18
18
155
54
166
3.29
14.48
1.1
1.1
1.01
1.14
u/l
1.16
31
89
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
54
168
3.25
14.21
1.0
1.1
—
—
—
0
0
59
196
3.04
13.92
1.1
1.1
319.62
257.79
mg/l
0.85
53
170
416
2826
1.53
13.81
6.6
6.3
1.44
1.32
mmol/l
1.07
408
2760
57
187
3.08
13.75
1.1
1.1
—
—
—
0
0
318
2033
1.62
13.75
1.2
1.3
40.88
49.89
au/ml
—
8
123
23
37
6.25
13.73
2.0
1.2
—
—
—
0
0
318
2051
1.60
13.25
1.7
1.7
—
—
—
0
0
85
353
2.44
13.08
1.8
1.3
284.23
275.67
mosm/kgh2o
2.72
71
265
231
1379
1.72
12.99
6.1
5.5
0.94
0.89
%
1.01
215
1288
3213
30224
1.42
12.91
16.9
14.0
78.87
77.39
ml/min/173m2
3.99
2844
24988
1423
12068
1.29
12.04
3.5
3.4
2.36
2.36
mmol/l
0.10
1214
10470
291
1882
1.59
11.98
1.4
1.5
—
—
—
0
0
680
5196
1.38
11.95
3.0
2.9
3.92
3.30
e6/l
0.65
393
2780
200
1177
1.74
11.86
2.7
2.2
10.92
11.94
nmol/l
0.96
169
1035
729
5650
1.36
11.69
2.8
2.7
1.10
1.31
e6/l
0.77
439
3218
867
6898
1.33
11.68
2.8
2.6
6.31
6.12
e6/l
0.14
793
6155
572
4274
1.40
11.47
7.8
7.2
—
—
—
0
0
512
3789
1.41
10.83
1.7
1.7
—
—
—
0
0
991
8117
1.30
10.69
1.5
1.6
20.23
21.18
nmol/l
1.11
847
6826
33
91
3.65
10.51
1.0
1.2
—
—
—
0
0
3295
31372
1.39
10.20
5.2
4.8
5.89
5.94
mmol/l
2.10
2978
28372
3507
33779
1.52
10.18
12.5
11.0
25.05
24.60
u/l
0.62
3400
32478
3155
29839
1.35
10.16
6.3
6.0
39.77
39.96
mmol/mol
0.58
2897
27348
397
2838
1.45
10.16
3.8
3.4
87.26
86.34
ng/l
0.08
339
2388
135
743
1.85
10.06
7.7
7.9
107.47
104.97
mmol/l
7.42
119
662
2896
27078
1.30
10.04
21.9
17.8
15.68
15.19
%
3.42
2852
26590
1241
10533
1.27
9.93
2.5
2.5
61.01
66.08
u/l
0.25
1124
9661
505
3783
1.39
9.90
1.7
1.8
—
—
—
0
0
205
1282
1.63
9.72
1.8
1.8
—
—
—
0
0
1210
10265
1.26
9.66
3.1
3.2
31.05
33.75
u/l
0.92
1134
9722
1182
10002
1.26
9.63
3.0
3.0
1410.54
1391.64
ng/l
0.05
1005
8579
1551
13541
1.25
9.61
3.0
2.8
122.96
123.26
ug/l
0.02
1406
12415
881
7205
1.29
9.43
2.0
1.7
1.42
1.23
mg/l
0.38
686
5520
1790
15921
1.24
9.21
4.3
4.0
0.00
0.00
estimate
0.15
376
3146
1811
16130
1.24
9.19
4.3
4.0
0.00
0.00
estimate
1.32
342
2885
1791
15944
1.23
9.10
5.9
5.4
0.00
0.00
estimate
0.80
352
2900
20
42
4.78
9.05
1.3
1.2
50.62
51.35
%
0.02
13
20
151
891
1.72
8.94
1.8
1.6
—
—
—
0
0
211
1360
1.58
8.85
1.8
1.9
37.62
39.38
u/l
0.69
181
1215
214
1387
1.58
8.77
2.1
1.9
—
—
—
0
0
3586
34822
1.57
8.71
28.3
22.3
39.43
39.50
%
0.32
3349
32373
119
660
1.83
8.70
1.7
1.9
5.50
4.90
mmol/24h
1.09
101
560
35
115
3.06
8.54
1.1
1.1
1575.82
441.10
ng/l
—
6
30
3586
34849
1.56
8.36
28.3
22.2
255.04
254.23
e9/l
0.30
3526
33918
3587
34868
1.55
8.26
28.4
22.3
132.22
132.84
g/l
2.04
3556
34326
3586
34857
1.55
8.25
28.3
22.2
6.89
6.68
e9/l
4.76
3520
33797
3586
34862
1.55
8.19
28.3
22.2
4.42
4.41
e12/l
0.37
3519
33806
1590
14087
1.22
8.13
10.4
9.7
0.00
0.00
e9/l
0.55
1298
11439
417
3132
1.37
8.00
2.5
2.3
30.20
38.62
u/l
3.67
363
2663
142
857
1.68
7.78
1.8
1.4
15.66
20.12
iu/ml
—
7
20
484
3744
1.34
7.66
2.3
2.6
7.54
7.99
umol/l
0.14
405
3250
20
49
4.10
7.53
2.6
3.1
44.00
39.78
umol/l
0.32
20
38
35
124
2.84
7.52
1.1
1.1
—
—
—
0
0
3345
32195
1.34
7.39
5.5
5.2
2.77
2.76
mmol/l
0.11
3048
29369
320
2339
1.40
7.23
3.1
2.7
9.78
10.45
g/l
2.45
291
2130
540
4285
1.30
7.11
4.8
4.7
33.11
33.36
%
0.23
378
2830
988
8446
1.23
6.91
2.3
2.3
2.95
3.03
mg/l
0.43
830
7183
337
2510
1.38
6.81
1.6
1.6
—
—
—
0
0
880
7447
1.24
6.75
1.7
1.7
10321220.39
28022691.73
pmol/l
0.85
717
6113
3274
31490
1.30
6.71
4.9
4.6
4.71
4.73
mmol/l
0.62
2997
28869
28
94
2.99
6.64
1.3
1.2
18.42
17.14
%
0.04
12
14
3248
31226
1.28
6.55
4.9
4.6
1.50
1.53
mmol/l
4.09
2947
28436
1953
17908
1.19
6.28
2.8
2.7
—
—
—
0
0
38
156
2.45
6.18
2.0
2.7
788.68
1526.32
u/ml
0.97
38
156
21
62
3.40
6.13
1.1
1.1
—
—
—
0
0
134
850
1.60
6.11
2.9
2.5
3.41
3.57
g/l
0.77
128
802
132
835
1.60
6.09
2.7
2.3
183.19
195.40
%
0.97
127
791
269
1979
1.39
5.88
3.9
3.7
5.19
5.17
kpa
0.11
248
1877
3132
30112
1.23
5.48
4.4
4.1
1.29
1.28
mmol/l
0.19
2815
27124
60
313
1.93
5.44
2.7
2.9
—
—
—
0
0
371
2902
1.31
5.42
2.4
2.4
6.95
6.31
ug/l
0.27
302
2503
962
8372
1.20
5.41
2.7
2.6
3541.86
5357.20
umol/l
0.80
827
7225
789
6748
1.21
5.32
3.1
3.0
2.46
2.46
mmol/l
0.52
673
5917
254
1884
1.37
5.31
3.9
3.6
1.92
1.99
mmol/l
0.12
182
1427
126
821
1.55
5.18
1.8
1.8
4.29
4.74
iu/l
0.17
42
287
73
416
1.77
5.04
1.5
1.3
310.08
299.85
pmol/l
0.10
66
358
686
5818
1.22
5.02
1.3
1.3
33.48
34.72
iu/ml
0.08
211
1890
61
330
1.86
4.99
1.8
1.6
—
—
—
0
0
451
3658
1.26
4.96
4.3
4.1
242.66
248.78
u/l
0.23
423
3436
37
167
2.23
4.93
2.3
2.5
—
—
—
0
0
375
2979
1.29
4.88
2.5
2.9
160.16
194.84
ng/l
1.56
339
2719
127
846
1.52
4.75
1.9
2.0
12.50
11.58
mg/l
0.21
116
780
361
2867
1.29
4.72
2.3
2.7
65.24
66.26
g/l
2.03
322
2596
62
344
1.82
4.70
1.4
1.4
0.27
0.27
nmol/l
0.02
44
248
423
3438
1.26
4.58
3.6
3.5
—
—
—
0
0
10
15
6.68
4.46
1.3
1.3
—
—
—
0
0
97
621
1.58
4.36
2.0
2.9
28.48
33.53
umol/l
2.55
83
559
244
1859
1.33
4.33
1.9
1.8
1.33
1.41
g/l
0.25
216
1687
19
66
2.89
4.33
1.1
1.2
—
—
—
0
0
1007
8949
1.17
4.30
1.6
1.6
1.39
1.35
mmol/l
0.96
871
7472
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
155
1100
1.43
4.25
3.4
2.9
0.34
0.36
u/ml
0.14
86
644
151
1068
1.43
4.22
2.0
1.6
315.56
294.47
titre
—
9
47
170
1233
1.40
4.13
4.5
3.9
25.02
25.02
mmol/l
0.01
154
1125
526
4427
1.22
4.13
2.8
2.5
21.24
22.07
%
0.61
462
3719
17
57
2.99
4.12
1.4
1.3
99.77
82.92
ng/l
0.38
17
57
1325
12065
1.15
4.04
4.7
4.3
—
—
—
0
0
11
22
5.01
4.00
1.4
1.4
20.64
14.50
%
0.29
11
16
21
81
2.60
3.97
1.0
1.1
—
—
—
0
0
22
87
2.54
3.96
1.0
1.1
—
—
—
0
0
22
87
2.54
3.96
1.0
1.1
—
—
—
0
0
140
992
1.43
3.90
1.5
1.6
1.16
1.19
g/l
0.54
130
944
11
23
4.79
3.86
1.4
1.3
22.00
42.63
%
0.86
11
16
13
33
3.95
3.79
1.0
1.2
—
—
—
0
0
55
316
1.75
3.78
5.7
4.6
12.91
48.32
u/ml
3.37
17
85
211
1608
1.33
3.78
3.0
2.7
0.50
0.30
e6/l
0.47
206
1562
54
309
1.76
3.77
1.9
1.6
—
—
—
0
0
152
1103
1.39
3.72
3.5
3.3
30.84
109.29
mg/l
0.92
126
917
353
2881
1.25
3.71
4.2
3.7
1.24
1.23
mmol/l
0.47
312
2481
177
1320
1.36
3.67
1.2
1.3
0.20
1.37
u/ml
2.33
13
124
78
497
1.58
3.64
1.4
1.3
0.60
0.65
nmol/l
0.85
73
476
21
85
2.48
3.62
1.1
1.1
202.08
318.68
pmol/l
1.27
12
63
134
957
1.41
3.60
1.6
1.6
0.23
0.24
g/l
0.71
123
911
151
1103
1.38
3.57
3.5
3.3
28.70
55.09
mg/l
1.44
125
915
126
892
1.43
3.56
1.2
1.3
—
—
—
0
0
554
4752
1.19
3.56
2.6
2.4
2.31
2.33
g/l
0.42
507
4375
359
2951
1.24
3.55
3.8
3.5
1.64
2.07
mmol/l
1.50
312
2520
102
698
1.47
3.45
1.5
1.3
—
—
—
0
0
102
698
1.47
3.45
1.5
1.3
—
—
—
0
0
636
5539
1.18
3.42
1.3
1.3
9.99
12.67
u/ml
0.43
240
2073
146
1070
1.38
3.40
3.5
3.3
1.07
1.51
ratio
—
7
92
9
18
5.01
3.37
1.2
1.2
2.67
0.75
%
—
9
12
84
556
1.52
3.35
2.0
1.6
—
—
—
0
0
358
2975
1.22
3.21
3.9
3.5
5.73
5.84
kpa
1.38
350
2895
19
78
2.44
3.21
3.4
2.5
—
—
—
0
0
108
760
1.43
3.19
1.8
1.5
—
—
—
0
0
50
296
1.70
3.15
1.1
1.1
—
—
—
0
0
945
8528
1.14
3.15
4.8
4.5
0.00
0.00
estimate
1.49
342
2844
17
67
2.54
3.12
1.1
1.0
—
—
—
0
0
591
5157
1.17
3.11
2.7
2.4
12.51
12.67
umol/l
0.18
552
4770
305
2506
1.24
3.06
4.3
3.9
1.03
0.70
%
0.43
107
807
8
16
5.01
3.05
1.0
1.1
—
—
—
0
0
167
1279
1.32
2.96
2.1
1.9
2.36
1.91
ug/l
0.20
133
1117
675
5975
1.16
2.95
1.5
1.4
2.26
2.44
g/l
1.59
392
3460
10
27
3.71
2.87
1.0
1.0
—
—
—
0
0
104
743
1.41
2.86
1.8
1.5
—
—
—
0
0
52
323
1.62
2.77
3.4
3.4
62.58
56.95
%
1.12
45
272
125
930
1.36
2.72
1.2
1.3
31.13
45.05
u/ml
—
10
60
18
79
2.28
2.67
1.2
1.1
—
—
—
0
0
294
2446
1.22
2.65
3.8
2.9
4.75
4.52
kpa
0.87
284
2372
12
43
2.80
2.64
1.0
1.2
—
—
—
0
0
12
41
2.93
2.61
1.0
1.2
—
—
—
0
0
18
80
2.26
2.60
1.1
1.1
0.69
0.69
umol/24h
0.03
11
41
124
933
1.34
2.53
1.5
1.5
0.13
6.20
iu/ml
0.52
28
204
21
101
2.09
2.52
1.6
1.2
34.64
38.96
g/l
1.17
15
51
313
2640
1.20
2.46
3.1
2.6
63.85
63.86
ml/min/173m2
0.00
116
1092
12
45
2.67
2.45
1.1
1.0
—
—
—
0
0
19
89
2.14
2.44
1.1
1.3
112.09
118.42
nmol/l
0.08
11
63
373
3200
1.18
2.43
2.1
2.1
0.22
0.21
g/l
1.32
343
2991
66
448
1.48
2.43
1.2
1.2
5.06
3.89
u/ml
0.16
16
134
104
768
1.36
2.41
1.3
1.2
—
—
—
0
0
54
352
1.54
2.40
1.6
1.5
—
—
—
0
0
10
33
3.04
2.35
1.0
1.1
—
—
—
0
0
136
1050
1.31
2.34
1.3
1.3
—
—
—
0
0
28
154
1.82
2.33
1.9
1.6
5.90
5.29
nmol/l
0.06
23
128
65
444
1.47
2.33
1.2
1.2
2.83
4.80
u/ml
1.16
24
176
174
1388
1.27
2.33
2.0
2.4
3.36
3.63
g/l
3.01
153
1244
93
679
1.38
2.32
1.2
1.3
22.28
45.82
u/ml
—
10
79
174
1389
1.26
2.31
2.0
2.4
—
—
—
0
0
164
1301
1.27
2.30
2.0
2.4
2.91
2.99
g/l
0.47
143
1156
13
53
2.46
2.27
1.2
1.1
—
—
—
0
0
54
357
1.52
2.27
1.6
1.4
32.46
36.74
u/l
0.39
47
290
12
47
2.56
2.27
1.3
1.5
—
—
—
0
0
18
86
2.10
2.22
1.0
1.1
—
—
—
0
0
92
676
1.37
2.22
2.8
2.5
15.50
16.06
%
0.61
46
340
11
41
2.69
2.20
1.1
1.1
1.52
1.71
umol/24h
0.44
11
41
11
41
2.69
2.20
1.0
1.0
—
—
—
0
0
173
1390
1.26
2.19
2.0
2.4
7.23
7.55
g/l
1.63
152
1243
38
233
1.64
2.19
1.0
1.0
869.48
698.76
ng/l
0.99
25
144
18
87
2.07
2.16
1.0
1.1
—
—
—
0
0
91
671
1.36
2.16
2.9
2.9
8.45
8.04
kpa
0.52
91
656
763
6950
1.12
2.15
4.8
4.5
1.02
1.02
kg/l
0.21
137
1053
63
436
1.45
2.14
1.7
1.5
—
—
—
0
0
124
959
1.30
2.14
1.7
1.7
—
—
—
0
0
38
235
1.62
2.13
1.0
1.0
33.74
45.47
ng/l
1.39
27
146
45
291
1.55
2.11
1.1
1.2
—
—
—
0
0
194
1588
1.23
2.10
3.8
3.2
25.28
25.44
mmol/l
0.32
188
1545
25
138
1.82
2.09
1.0
1.2
—
—
—
0
0
77
556
1.39
2.08
4.5
5.2
268.42
598.45
iu/ml
0.66
12
80
13
56
2.33
2.04
1.1
1.1
—
—
—
0
0
38
238
1.60
2.04
1.2
1.1
110.00
174.29
titre
—
5
42
12
50
2.40
2.02
1.1
1.0
—
—
—
0
0
71
509
1.40
2.01
1.2
1.2
—
—
—
0
0
17
83
2.05
2.01
1.1
1.1
83.11
88.15
%
—
9
39
760
6949
1.12
2.00
1.3
1.3
0.79
1.67
u/ml
5.50
183
1796
63
443
1.43
1.99
1.1
1.1
—
—
—
0
0
64
452
1.42
1.98
2.4
2.2
37.56
25.88
mg/l
0.61
16
114
45
296
1.53
1.97
2.4
2.3
—
—
—
0
0
70
503
1.40
1.96
2.2
1.8
3712.23
2944.01
u/l
0.10
24
194
130
1025
1.28
1.96
1.7
1.8
—
—
—
0
0
17
84
2.03
1.95
1.2
1.3
107.17
63.75
mu/l
—
10
66
33
202
1.64
1.95
1.6
1.4
0.91
1.07
promille
0.21
24
157
8
27
2.97
1.93
1.0
1.1
—
—
—
0
0
16
78
2.06
1.90
1.0
1.1
—
—
—
0
0
62
439
1.42
1.90
2.2
2.5
256.00
1033.29
u/ml
—
5
31
70
507
1.39
1.89
1.9
1.5
—
—
—
0
0
70
507
1.39
1.89
1.9
1.5
—
—
—
0
0
159
1291
1.24
1.88
2.1
2.4
9.38
10.14
g/l
1.72
138
1135
425
3765
1.15
1.87
2.0
2.1
114.46
135.20
ug/g
0.83
321
2934
96
733
1.32
1.85
2.2
2.2
126.34
127.36
g/l
0.16
64
518
518
4660
1.13
1.80
1.4
1.4
—
—
—
0
0
36
231
1.56
1.78
1.0
1.0
313.67
329.19
ng/l
0.11
27
145
47
320
1.47
1.78
3.0
3.9
—
—
—
0
0
68
496
1.38
1.78
1.5
1.4
—
—
—
0
0
380
3356
1.15
1.76
3.4
3.2
0.86
0.76
ug/l
0.60
278
2325
129
1032
1.26
1.76
1.4
1.4
309.18
282.22
ug/g
0.75
71
600
19
102
1.87
1.76
1.5
1.5
2.36
3.56
umol/l
1.47
19
92
56
396
1.42
1.75
2.0
1.5
61.58
59.26
%
0.19
41
250
20
110
1.82
1.72
1.8
1.4
169.80
81.46
nmol/24h
0.49
20
110
20
110
1.82
1.72
1.1
1.1
1639.87
1686.67
miu/ml
0.05
20
110
232
1978
1.18
1.70
3.5
3.1
127.52
127.51
g/l
0.00
226
1928
24
141
1.71
1.68
1.2
1.3
169.04
149.49
mmol/24h
0.69
24
141
639
5855
1.11
1.63
5.9
5.3
2.56
3.96
ug/l
1.11
570
5177
87
670
1.31
1.62
1.6
1.6
—
—
—
0
0
100
786
1.28
1.60
2.8
3.2
24.85
25.06
mmol/l
0.23
100
771
72
541
1.34
1.59
3.7
3.5
1.75
1.47
%
0.19
63
476
16
84
1.91
1.59
1.1
1.3
86.89
89.59
%
—
9
41
250
2160
1.17
1.58
1.2
1.2
165.50
151.16
iu/ml
0.21
84
815
11
50
2.20
1.57
1.2
1.6
81.00
116.75
ug/l
—
6
44
13
64
2.03
1.54
1.3
1.2
—
—
—
0
0
415
3724
1.13
1.53
2.5
2.4
1.79
1.83
%
0.28
373
3280
134
1097
1.23
1.53
2.0
2.3
37.04
37.45
g/l
0.35
113
948
144
1190
1.22
1.50
2.1
2.4
0.57
0.94
g/l
1.16
125
1024
40
275
1.46
1.49
2.2
1.6
—
—
—
0
0
40
275
1.46
1.49
2.2
1.6
—
—
—
0
0
40
275
1.46
1.49
2.2
1.6
—
—
—
0
0
108
868
1.25
1.46
1.2
1.3
15.06
7.76
u/ml
0.35
17
160
331
2939
1.14
1.45
1.6
1.7
1.43
1.46
%
0.29
276
2549
38
260
1.47
1.45
1.6
1.5
—
—
—
0
0
18
102
1.77
1.44
2.1
1.6
0.47
0.38
ug/l
0.16
12
61
62
464
1.34
1.43
1.3
1.3
116.00
119.46
u/ml
0.10
11
96
106
857
1.24
1.38
1.2
1.3
2.13
6.27
u/ml
—
10
94
23
142
1.62
1.38
1.3
1.2
—
—
—
0
0
1038
9808
1.08
1.34
3.1
3.2
596.74
364.10
mg/l
0.61
634
5950
63
479
1.32
1.33
1.2
1.2
306.38
295.62
u/ml
0.12
39
281
313
2796
1.13
1.28
2.8
2.4
70.28
70.42
e9/l
0.02
247
2102
8
35
2.29
1.26
2.0
2.9
0.38
0.74
u/field
—
8
35
28
186
1.51
1.26
1.1
1.1
1.04
1.04
ratio
—
8
62
1071
10157
1.08
1.25
3.1
3.1
6.78
6.82
mmol/l
0.10
891
8490
116
961
1.21
1.23
2.1
2.4
0.00
0.00
g/l
-0.00
107
891
57
434
1.32
1.21
1.7
1.4
—
—
—
0
0
5
19
2.63
1.21
1.0
1.0
—
—
—
0
0
106
872
1.22
1.21
1.8
1.4
—
—
—
0
0
510
4699
1.10
1.19
4.9
4.5
22.31
21.52
%
0.61
275
2387
15
86
1.75
1.18
1.1
1.2
—
—
—
0
0
96
784
1.23
1.18
1.4
1.3
—
—
—
0
0
117
976
1.21
1.17
2.1
2.4
0.00
0.00
g/l
-0.00
107
893
10
50
2.00
1.16
1.7
1.8
—
—
—
0
0
59
456
1.30
1.15
1.6
1.4
—
—
—
0
0
25
166
1.51
1.14
1.2
1.3
137.06
132.85
nmol/l
0.27
25
166
124
1043
1.20
1.14
2.0
2.4
0.00
0.02
g/l
1.36
114
955
18
282
0.64
1.11
1.3
1.5
—
—
—
0
0
34
242
1.41
1.11
1.1
1.1
—
—
—
0
0
58
450
1.29
1.10
1.6
1.4
—
—
—
0
0
7
31
2.26
1.10
1.7
2.5
—
—
—
0
0
29
201
1.45
1.09
1.7
1.4
—
—
—
0
0
58
452
1.29
1.07
1.6
1.4
—
—
—
0
0
46
347
1.33
1.07
1.5
1.4
—
—
—
0
0
46
347
1.33
1.07
1.5
1.4
—
—
—
0
0
84
685
1.23
1.07
1.6
1.5
—
—
—
0
0
83
676
1.23
1.07
1.3
1.3
188.94
211.78
miu/ml
0.21
33
306
58
453
1.28
1.06
1.6
1.4
—
—
—
0
0
1084
10343
1.07
1.06
3.7
3.7
7.38
8.37
mg/mmol
0.27
651
6211
73
587
1.25
1.06
1.7
2.0
0.78
0.79
nmol/l
0.07
65
488
7
33
2.12
1.05
1.0
1.1
—
—
—
0
0
20
129
1.55
1.05
2.8
1.8
—
—
—
0
0
20
129
1.55
1.05
2.9
1.8
—
—
—
0
0
59
463
1.28
1.04
1.6
1.4
—
—
—
0
0
24
162
1.48
1.04
2.6
1.7
—
—
—
0
0
24
162
1.48
1.04
2.6
1.7
—
—
—
0
0
13
75
1.74
1.02
1.2
1.2
—
—
—
0
0
20
130
1.54
1.02
2.9
1.8
—
—
—
0
0
33
239
1.38
1.00
1.2
1.2
—
—
—
0
0
34
460
0.74
0.99
1.4
1.5
—
—
—
0
0
45
343
1.32
0.99
3.8
5.7
6.97
7.36
mmol/l
0.52
39
285
33
240
1.38
0.98
1.2
1.2
—
—
—
0
0
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
57
450
1.27
0.98
1.6
1.4
—
—
—
0
0
416
3840
1.09
0.97
3.5
3.9
13.81
22.10
ug/l
0.42
337
3098
33
241
1.37
0.96
1.2
1.2
—
—
—
0
0
33
241
1.37
0.96
1.2
1.2
—
—
—
0
0
33
241
1.37
0.96
1.2
1.2
—
—
—
0
0
31
225
1.38
0.94
1.5
1.3
—
—
—
0
0
18
269
0.67
0.93
1.2
1.4
—
—
—
0
0
18
268
0.67
0.91
1.2
1.4
—
—
—
0
0
116
995
1.17
0.90
1.3
1.2
—
—
—
0
0
18
267
0.67
0.90
1.2
1.4
—
—
—
0
0
18
267
0.67
0.90
1.2
1.4
—
—
—
0
0
29
393
0.74
0.88
1.1
1.1
1.59
1.53
g/l
0.26
24
350
24
170
1.41
0.85
1.8
1.9
0.80
3.16
u/field
1.41
15
121
13
80
1.63
0.84
1.1
1.1
—
—
—
0
0
16
104
1.54
0.84
1.7
1.8
19.29
66.91
u/l
1.22
16
98
33
248
1.33
0.83
1.3
1.2
—
—
—
0
0
31
231
1.34
0.82
1.5
1.3
—
—
—
0
0
114
987
1.16
0.81
1.3
1.2
—
—
—
0
0
14
89
1.58
0.81
1.3
1.2
—
—
—
0
0
92
785
1.18
0.79
1.4
1.3
—
—
—
0
0
86
731
1.18
0.78
1.7
1.6
—
—
—
0
0
34
260
1.31
0.77
1.2
1.2
—
—
u/ml
—
0
0
31
406
0.76
0.77
1.4
1.5
1731.67
2193.70
e6/l
0.34
24
298
37
287
1.29
0.77
1.4
1.4
—
—
—
0
0
6
34
1.77
0.76
1.5
1.4
—
—
—
0
0
15
221
0.68
0.75
1.4
1.5
—
—
—
0
0
5
24
2.08
0.74
1.0
5.4
—
—
—
0
0
24
175
1.37
0.74
1.8
1.5
—
—
—
0
0
194
2144
0.90
0.74
1.8
1.7
—
—
—
0
0
52
423
1.23
0.74
1.6
1.4
—
—
—
0
0
88
754
1.17
0.73
1.2
1.1
—
—
—
0
0
175
1573
1.12
0.73
1.1
1.1
—
—
—
0
0
24
176
1.37
0.72
1.8
1.5
—
—
—
0
0
18
125
1.44
0.72
1.1
1.5
33.31
31.12
umol/l
0.49
18
120
237
2168
1.10
0.72
3.1
3.9
31.76
65.18
u/ml
2.80
228
2085
66
553
1.20
0.71
1.6
1.4
—
—
—
0
0
90
775
1.17
0.71
3.7
3.2
0.78
0.82
nmol/l
0.76
68
599
36
282
1.28
0.71
2.0
2.2
1.47
2.07
u/field
0.57
15
107
5
26
1.92
0.70
1.2
1.2
—
—
—
0
0
207
1884
1.10
0.70
1.3
1.2
173.31
171.44
u/ml
0.01
186
1729
7
41
1.71
0.70
2.0
1.9
19.99
19.80
umol/l
—
7
41
58
483
1.20
0.68
1.5
1.4
—
—
—
0
0
37
293
1.27
0.67
1.8
1.5
22.71
33.16
%
1.13
25
182
14
94
1.49
0.66
1.2
1.2
—
—
—
0
0
5
28
1.79
0.66
1.0
1.4
—
—
—
0
0
22
162
1.36
0.66
1.2
1.2
160.47
268.23
u/l
0.75
17
148
18
128
1.41
0.65
2.7
2.0
19.30
79.09
ug/l
0.48
18
115
17
120
1.42
0.64
1.0
1.1
—
—
—
0
0
88
765
1.15
0.64
2.8
3.1
1.59
1.61
mg/l
0.07
83
702
50
414
1.21
0.63
1.1
1.3
40.90
49.76
u/ml
—
5
27
39
315
1.24
0.62
1.1
1.1
0.47
1.09
u/ml
0.93
17
154
30
235
1.28
0.61
1.7
1.5
—
—
—
0
0
54
453
1.19
0.60
1.4
1.6
—
—
—
0
0
17
122
1.40
0.60
1.5
2.4
227.29
155.72
umol/l
—
7
68
6
35
1.72
0.57
34.8
13.4
4.45
5.14
mmol/l
—
6
35
164
1496
1.10
0.56
1.3
1.3
—
—
—
0
0
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
6
36
1.67
0.56
2.7
1.6
—
—
—
0
0
24
307
0.78
0.55
1.3
1.4
—
—
—
0
0
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
22
169
1.30
0.53
1.0
1.1
—
—
—
0
0
139
1264
1.10
0.52
3.1
3.2
2824.64
3500.06
u/ml
0.09
115
1061
30
241
1.25
0.52
1.9
2.3
655.67
633.44
ml
0.12
18
160
165
1520
1.09
0.48
1.7
1.7
—
—
—
0
0
49
418
1.17
0.48
1.1
1.1
0.55
1.29
u/ml
1.02
20
218
20
154
1.30
0.48
1.3
1.3
—
—
—
0
0
123
1118
1.10
0.48
3.0
2.8
—
—
—
0
0
47
401
1.17
0.47
2.7
2.0
4436.93
1010.06
u/ml
0.36
47
396
26
209
1.25
0.46
1.8
1.6
—
—
—
0
0
162
1496
1.09
0.46
1.8
1.7
1.54
1.58
g/l
0.20
141
1277
89
798
1.12
0.45
1.4
1.5
—
—
—
0
0
9
128
0.70
0.43
9.4
13.0
970.22
834.05
nmol/l
—
9
122
21
166
1.27
0.43
1.6
1.3
—
—
—
0
0
21
166
1.27
0.43
1.6
1.3
—
—
—
0
0
22
175
1.26
0.43
1.1
1.4
1.59
1.61
g/l
0.13
22
175
14
185
0.76
0.43
1.4
1.6
—
—
—
0
0
30
360
0.83
0.42
1.4
1.5
6845.65
77292.29
e6/l
2.27
20
208
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
5
33
1.52
0.41
3.4
5.2
71.60
62.36
ug/min
—
5
28
26
213
1.22
0.40
1.2
1.2
—
—
—
0
0
5
34
1.47
0.40
1.2
1.0
—
—
—
0
0
8
61
1.31
0.39
2.8
1.5
—
—
—
0
0
0
19
0.00
0.39
0.0
1.3
—
23.26
—
0
8
14
106
1.32
0.39
2.9
1.7
—
—
—
0
0
27
224
1.21
0.38
1.5
1.5
0.93
0.97
g/l
0.29
27
224
184
1726
1.07
0.38
1.8
1.8
—
—
—
0
0
23
189
1.22
0.36
1.3
1.2
—
—
—
0
0
20
162
1.24
0.35
1.0
1.1
—
—
—
0
0
43
376
1.15
0.35
1.2
1.2
59.52
57.84
u/l
0.10
37
346
6
44
1.36
0.34
1.8
2.3
—
—
—
0
0
41
358
1.15
0.34
1.0
1.1
2.46
2.80
u/ml
0.12
19
171
40
349
1.15
0.33
1.1
1.1
0.95
1.22
u/ml
0.16
14
144
52
463
1.12
0.33
1.2
1.1
—
—
—
0
0
10
74
1.35
0.32
1.0
1.1
—
—
—
0
0
10
74
1.35
0.32
1.2
1.5
—
—
—
0
0
23
192
1.20
0.32
1.3
1.2
—
—
—
0
0
7
99
0.71
0.30
1.4
1.6
9.69
8.74
ug/l
—
7
99
111
1191
0.93
0.30
1.3
1.3
—
—
—
0
0
10
75
1.33
0.30
1.1
1.1
—
—
—
0
0
12
93
1.29
0.30
1.2
1.4
157.41
143.60
pmol/l
0.22
12
93
77
838
0.92
0.29
1.6
1.8
—
—
—
0
0
47
420
1.12
0.29
1.0
1.1
—
—
—
0
0
27
232
1.16
0.28
1.3
1.6
5.17
6.38
u/l
0.34
20
194
17
204
0.83
0.26
1.1
1.3
7.91
8.98
mmol/l
0.51
17
195
25
215
1.16
0.26
1.6
1.6
77.48
78.52
umol/l
0.07
25
215
21
178
1.18
0.26
1.0
1.0
—
—
—
0
0
68
738
0.92
0.26
2.1
2.3
80.56
96.97
ug/min
0.18
30
428
35
310
1.13
0.26
1.1
1.2
—
—
—
0
0
100
937
1.07
0.25
1.8
1.6
—
—
—
0
0
12
148
0.81
0.24
1.4
1.5
—
—
—
0
0
66
712
0.93
0.23
3.2
3.8
31.22
26.10
mg/l
0.32
31
434
19
162
1.17
0.22
1.1
1.2
—
—
—
0
0
31
276
1.12
0.22
3.6
2.0
—
—
—
0
0
29
257
1.13
0.22
1.1
1.1
6.08
2.85
u/ml
0.50
11
98
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
88
827
1.07
0.21
1.0
1.1
2.60
6.16
u/ml
—
7
82
13
156
0.83
0.21
2.4
1.8
1.09
5.24
ug/l
—
8
116
0
13
0.00
0.21
0.0
3.2
—
—
—
0
0
0
13
0.00
0.21
0.0
2.3
—
3.66
—
0
13
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
2.43
—
0
14
6
48
1.25
0.20
1.0
1.3
—
—
—
0
0
64
600
1.07
0.17
1.2
1.3
—
—
—
0
0
7
61
1.15
0.17
1.0
1.1
—
—
—
0
0
39
358
1.09
0.17
1.5
1.7
—
—
—
0
0
7
62
1.13
0.17
1.9
1.5
—
—
—
0
0
41
444
0.92
0.17
1.2
1.1
12.44
1432.02
iu/ml
—
9
91
8
68
1.18
0.16
1.0
1.0
—
—
—
0
0
14
161
0.87
0.15
3.0
4.2
—
—
—
0
0
28
256
1.09
0.14
1.0
1.0
—
—
—
0
0
9
107
0.84
0.13
1.7
1.8
—
—
—
0
0
23
209
1.10
0.13
1.9
1.9
—
—
—
0
0
105
1014
1.04
0.11
1.8
1.7
3.94
3.75
mg/l
0.09
86
775
5
45
1.11
0.09
2.0
2.3
—
—
—
0
0
10
114
0.88
0.09
2.1
1.3
—
—
—
0
0
85
822
1.03
0.09
2.0
1.6
8078.23
11147.85
e6/l
0.91
69
594
20
217
0.92
0.09
1.0
1.2
0.10
0.92
u/ml
—
7
117
70
726
0.96
0.09
2.9
3.2
492.92
774.10
u/ml
0.20
62
660
68
655
1.04
0.09
3.0
3.6
56.32
57.73
%
0.40
68
655
7
64
1.09
0.08
1.0
1.3
—
—
—
0
0
17
156
1.09
0.08
3.6
2.9
—
—
—
0
0
17
156
1.09
0.08
1.3
1.2
—
—
—
0
0
44
421
1.05
0.07
1.1
1.1
—
—
—
0
0
9
85
1.06
0.07
1.1
2.8
—
—
—
0
0
9
85
1.06
0.07
1.1
2.8
—
—
—
0
0
8
91
0.88
0.06
1.1
1.1
—
—
—
0
0
37
354
1.05
0.06
1.0
1.1
—
—
—
0
0
18
168
1.07
0.06
1.1
1.4
—
—
—
0
0
18
168
1.07
0.06
1.1
1.4
—
—
—
0
0
40
386
1.04
0.05
1.1
1.0
3.70
3.28
u/ml
0.08
17
154
101
1028
0.98
0.04
1.5
1.5
—
—
—
0
0
21
221
0.95
0.04
1.2
1.2
86.47
77.35
u/l
0.34
15
198
31
322
0.96
0.04
1.8
1.3
19008.62
90738.80
e6/l
1.17
21
209
17
163
1.04
0.01
1.0
1.1
—
—
—
0
0
52
512
1.02
0.01
1.1
1.2
27.12
36.31
u/l
0.45
46
435
21
214
0.98
0.00
1.2
1.2
19.50
20.22
u/l
0.04
16
187
28
276
1.01
0.00
2.0
1.5
32.20
21.19
u/ml
—
5
54
16
156
1.03
0.00
1.1
1.1
—
—
—
0
0
17
166
1.02
0.00
3.4
2.6
42.45
41.90
%
0.04
11
92
570
5698
1.00
0.00
1.4
1.4
—
—
—
0
0
9
96
0.94
0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
6
62
0.97
-0.00
1.2
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
53
0.94
-0.00
1.6
2.7
15.52
14.47
ml/dl
—
5
47
0
6
0.00
-0.00
0.0
2.0
—
1.15
—
0
6
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
8
82
0.98
-0.00
2.1
1.8
0.99
0.98
mmol/l
—
8
75
0
5
0.00
-0.00
0.0
8.2
—
74.60
—
0
5
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
5.0
—
377.78
—
0
9
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_MENINGES_CEREBRAL and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_MENINGES_CEREBRAL | 1.557 [1.41, 1.72] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.127 |
During the follow-up period (1.1.1998 — 31.12.2019), 2938 out of 11921 females with CD2_BENIGN_MENINGES_CEREBRAL died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_MENINGES_CEREBRAL | 1.748 [1.52, 2.01] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 1266 out of 3849 males with CD2_BENIGN_MENINGES_CEREBRAL died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_MENINGES_CEREBRAL.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.156% | 0.314% |
| 5 | 0.846% | 2.025% |
| 10 | 2.121% | 4.629% |
| 15 | 4.094% | 8.658% |
| 20 | 7.325% | 14.584% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_MENINGES_CEREBRAL – Benign neoplasm: Cerebral meninges
GWS hits: 10
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data